261 related articles for article (PubMed ID: 21415239)
21. Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer.
Häggström C; Van Hemelrijck M; Zethelius B; Robinson D; Grundmark B; Holmberg L; Gudbjörnsdottir S; Garmo H; Stattin P
Int J Cancer; 2017 Feb; 140(3):611-617. PubMed ID: 27770555
[TBL] [Abstract][Full Text] [Related]
22. The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma.
Wu W; Merriman K; Nabaah A; Seval N; Seval D; Lin H; Wang M; Qazilbash MH; Baladandayuthapani V; Berry D; Orlowski RZ; Lee MH; Yeung SC
Br J Cancer; 2014 Jul; 111(3):628-36. PubMed ID: 24921909
[TBL] [Abstract][Full Text] [Related]
23. Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in korea.
Jang WI; Kim MS; Kang SH; Jo AJ; Kim YJ; Tchoe HJ; Park CM; Kim HJ; Choi JA; Choi HJ; Paik EK; Seo YS; Yoo HJ; Kang JK; Han CJ; Kim YJ; Kim SB; Ko MJ
Oncotarget; 2017 Feb; 8(6):9587-9596. PubMed ID: 28077783
[TBL] [Abstract][Full Text] [Related]
24. Metformin use and risk of prostate cancer: results from the REDUCE study.
Feng T; Sun X; Howard LE; Vidal AC; Gaines AR; Moreira DM; Castro-Santamaria R; Andriole GL; Freedland SJ
Cancer Prev Res (Phila); 2015 Nov; 8(11):1055-60. PubMed ID: 26353947
[TBL] [Abstract][Full Text] [Related]
25. Impact of metformin use on survival outcomes in non-small cell lung cancer treated with platinum.
Wen-Xiu X; Xiao-Wei Z; Hai-Ying D; Ying-Hui T; Si-Si K; Xiao-Fang Z; Huang P
Medicine (Baltimore); 2018 Dec; 97(51):e13652. PubMed ID: 30572481
[TBL] [Abstract][Full Text] [Related]
26. Metformin may offer no protective effect in men undergoing external beam radiation therapy for prostate cancer.
Ranasinghe WKB; Williams S; Ischia J; Wetherell D; Baldwin G; Shulkes A; Sengupta S; Bolton D; Patel O
BJU Int; 2019 May; 123 Suppl 5():36-42. PubMed ID: 31012989
[TBL] [Abstract][Full Text] [Related]
27. Do endometrial cancer patients benefit from metformin intake?
Lemańska A; Zaborowski M; Spaczyński M; Nowak-Markwitz E
Ginekol Pol; 2015 Jun; 86(6):419-23. PubMed ID: 26255448
[TBL] [Abstract][Full Text] [Related]
28. Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer.
Medairos RA; Clark J; Holoubek S; Kubasiak JC; Pithadia R; Hamid F; Chmielewski GW; Warren WH; Basu S; Borgia JA; Liptay MJ; Seder CW
J Thorac Cardiovasc Surg; 2016 Jul; 152(1):55-61.e1. PubMed ID: 27157918
[TBL] [Abstract][Full Text] [Related]
29. Risk of overall mortality and cardiovascular events in patients with type 2 diabetes on dual drug therapy including metformin: A large database study from the Cleveland Clinic.
Kannan S; Pantalone KM; Matsuda S; Wells BJ; Karafa M; Zimmerman RS
J Diabetes; 2016 Mar; 8(2):279-85. PubMed ID: 25929426
[TBL] [Abstract][Full Text] [Related]
30. Continuous use of metformin can improve survival in type 2 diabetic patients with ovarian cancer: A retrospective study.
Wang SB; Lei KJ; Liu JP; Jia YM
Medicine (Baltimore); 2017 Jul; 96(29):e7605. PubMed ID: 28723808
[TBL] [Abstract][Full Text] [Related]
31. Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality.
Spratt DE; Zhang C; Zumsteg ZS; Pei X; Zhang Z; Zelefsky MJ
Eur Urol; 2013 Apr; 63(4):709-16. PubMed ID: 23287698
[TBL] [Abstract][Full Text] [Related]
32. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
Ou HT; Chang KC; Li CY; Wu JS
Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
[TBL] [Abstract][Full Text] [Related]
33. The Effect of Metformin on Survival Outcomes of Non-Metastatic Breast Cancer Patients with Type 2 Diabetes.
Behrouzi B; Zokaasadi M; Mohagheghi MA; Emami AH; Sadighi S
Asian Pac J Cancer Prev; 2021 Feb; 22(2):611-616. PubMed ID: 33639681
[TBL] [Abstract][Full Text] [Related]
34. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
35. A comparison of all-cause mortality with pioglitazone and insulin in type 2 diabetes: an expanded analysis from a retrospective cohort study.
Yang J; Vallarino C; Bron M; Perez A; Liang H; Joseph G; Yu S
Curr Med Res Opin; 2014 Nov; 30(11):2223-31. PubMed ID: 24983744
[TBL] [Abstract][Full Text] [Related]
36. Metformin use and survival after colorectal cancer: A population-based cohort study.
Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
[TBL] [Abstract][Full Text] [Related]
37. Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation.
Chen TM; Lin CC; Huang PT; Wen CF
J Gastroenterol Hepatol; 2011 May; 26(5):858-65. PubMed ID: 21251068
[TBL] [Abstract][Full Text] [Related]
38. Can metformin improve 'the tomorrow' of patients treated for oesophageal cancer?
Van De Voorde L; Janssen L; Larue R; Houben R; Buijsen J; Sosef M; Vanneste B; Schraepen MC; Berbée M; Lambin P
Eur J Surg Oncol; 2015 Oct; 41(10):1333-9. PubMed ID: 26091848
[TBL] [Abstract][Full Text] [Related]
39. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.
Strowig SM; Raskin P
Diabetes Obes Metab; 2005 Nov; 7(6):633-41. PubMed ID: 16219007
[TBL] [Abstract][Full Text] [Related]
40. Metformin Has a Positive Therapeutic Effect on Prostate Cancer in Patients With Type 2 Diabetes Mellitus.
Chong RW; Vasudevan V; Zuber J; Solomon SS
Am J Med Sci; 2016 Apr; 351(4):416-9. PubMed ID: 27079349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
